Dynavax Technologies (DVAX)

$10.67 0.00 (N/A)
Market Cap 1.25B
Revenue (ttm) 277.25M
Net Income (ttm) 27.31M
EPS (ttm) N/A
PE Ratio 76.71
Forward PE N/A
Profit Margin 9.85%
Debt to Equity Ratio 0.00
Volume 852,145
Avg Vol 2,013,120
Day's Range N/A - N/A
Shares Out 120.08M
Stochastic %K 63%
Beta 1.03
Analysts Sell
Price Target $22.00

Company Profile

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally. The company offers HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in adults aged 18 years and older; and CpG 1018, the adjuvant used in HEPLISAV-B. It also develops rF1V, a plague vaccine candidate in Phase 2 clinical trial; and Z-1018, an investigational vaccin...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 510 848 5100
Fax: 510 848 1327
Address:
2100 Powell Street, Suite 720, EmeryVille, United States
KWalzz
KWalzz Jul. 16 at 12:06 PM
$DVAX more than a year ago the lazy dynavax crookies received the CRL for their dialysis fail ... wow, only one update and no meeting with FDA since then ... hey, Myers and Spencer, stop slurping martinis, go to work, this 4dose regimen is approved in EU so why still nothing here? go to work you lazy morns and create shareholder value ...
1 · Reply
Barry64
Barry64 Jul. 15 at 3:04 PM
$DVAX Extremely low volume. Easily manipulated.
1 · Reply
KWalzz
KWalzz Jul. 14 at 7:47 PM
$DVAX the only way to get this moved up is good news regarding dialysis fail - but this would mean WORK, WORK, WORK for the lazy Spencer & Myers crookies. I see nothing else in the mid-term to move this, except maybe more activism by Deep Track, next ER is not so far away ...
0 · Reply
KWalzz
KWalzz Jul. 13 at 6:05 PM
$DVAX btw, for the ones who care about SI, for the 4th time pretty unchanged, bit of unusual, but I do not read too much into it.
1 · Reply
KWalzz
KWalzz Jul. 13 at 5:22 AM
$DVAX all these mice studies which often date back 2022 or more will eventually grow up to human studies in 2030 or so, or maybe not and never. useless paid pump scam ....
0 · Reply
KWalzz
KWalzz Jul. 13 at 5:17 AM
$DVAX like clockwork, another pump that sounds like coming from a bot, not very smart, but so sure 20s soooooooooon .....
0 · Reply
AccuRoger
AccuRoger Jul. 12 at 7:11 PM
$DVAX partner, Mount Sinai is moving forward with its Influenza vaccine that has previously used CpG 1018 in animal studies (see references 13 and 14). The details in this article are technical but are a precursor to human trials. There seems to be a growth plan for DVAX; however, management has not shared it with investors. https://www.sciencedirect.com/science/article/pii/S0264410X25007686
0 · Reply
KWalzz
KWalzz Jul. 10 at 7:11 PM
$DVAX yes, of course 20 soon ... so so sooooon ...
1 · Reply
Quantum_Capital_LLC
Quantum_Capital_LLC Jul. 10 at 7:08 PM
$DVAX will test the 15 wall (July'22, Sept'23, Feb'25) soon enough and I believe base on technical indicators it will break thru, testing 20 again for a +50% to +100% gain. Do your DD. Long term
2 · Reply
OhioTrader
OhioTrader Jul. 10 at 3:53 PM
$DVAX really. $10.99. you guys are a tease!
0 · Reply
Latest News on DVAX
Dynavax elects all four of its nominees after Deep Track proxy fight

Jun 11, 2025, 12:14 PM EDT - 5 weeks ago

Dynavax elects all four of its nominees after Deep Track proxy fight

Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting

Jun 11, 2025, 11:01 AM EDT - 5 weeks ago

Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting

Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom

Jun 9, 2025, 8:30 AM EDT - 5 weeks ago

Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom

Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting

Jun 9, 2025, 7:30 AM EDT - 5 weeks ago

Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting

Dynavax Comments on Glass Lewis Recommendation

Jun 4, 2025, 4:59 PM EDT - 6 weeks ago

Dynavax Comments on Glass Lewis Recommendation

Glass Lewis Recommends Shareholders Support Deep Track's Case for Board Change at Dynavax Technologies

Jun 4, 2025, 9:27 AM EDT - 6 weeks ago

Glass Lewis Recommends Shareholders Support Deep Track's Case for Board Change at Dynavax Technologies

Dynavax to Present at William Blair's 45th Annual Growth Stock Conference

May 28, 2025, 4:10 PM EDT - 7 weeks ago

Dynavax to Present at William Blair's 45th Annual Growth Stock Conference

Deep Track Capital Comments on ISS Recommendation

May 23, 2025, 6:12 PM EDT - 7 weeks ago

Deep Track Capital Comments on ISS Recommendation

ISS backs Dynavax directors in board fight with Deep Track Capital

May 23, 2025, 1:54 PM EDT - 7 weeks ago

ISS backs Dynavax directors in board fight with Deep Track Capital

Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote "FOR" All Four of Dynavax's Highly Qualified Director Nominees

May 23, 2025, 1:44 PM EDT - 7 weeks ago

Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote "FOR" All Four of Dynavax's Highly Qualified Director Nominees

Dynavax Technologies: Hepatitis-B Vaccine Specialist Looking Good

May 21, 2025, 11:48 PM EDT - 2 months ago

Dynavax Technologies: Hepatitis-B Vaccine Specialist Looking Good

Deep Track Capital Issues Letter to Fellow Dynavax Technologies Shareholders Detailing Critical Issues in Advance of Annual Meeting

May 15, 2025, 4:00 PM EDT - 2 months ago

Deep Track Capital Issues Letter to Fellow Dynavax Technologies Shareholders Detailing Critical Issues in Advance of Annual Meeting

Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value

May 12, 2025, 7:30 AM EDT - 2 months ago

Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value

Dynavax Issues Statement and Mails Letter to Stockholders Emphasizing Record Financial Results and Continued Momentum

May 7, 2025, 4:45 PM EDT - 2 months ago

Dynavax Issues Statement and Mails Letter to Stockholders Emphasizing Record Financial Results and Continued Momentum

Dynavax Technologies Corporation (DVAX) Q1 2025 Earnings Call Transcript

May 6, 2025, 7:34 PM EDT - 2 months ago

Dynavax Technologies Corporation (DVAX) Q1 2025 Earnings Call Transcript

Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs

May 6, 2025, 4:01 PM EDT - 2 months ago

Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs

Deep Track Capital Releases Investor Presentation on Dynavax Technologies

May 6, 2025, 8:00 AM EDT - 2 months ago

Deep Track Capital Releases Investor Presentation on Dynavax Technologies

Dynavax Announces Nationwide Harris Poll Survey Results Finding Americans Underestimate the Serious Consequences of Hepatitis B and Vaccine Protection Benefits

May 1, 2025, 8:00 AM EDT - 2 months ago

Dynavax Announces Nationwide Harris Poll Survey Results Finding Americans Underestimate the Serious Consequences of Hepatitis B and Vaccine Protection Benefits

Dynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy

Apr 29, 2025, 7:30 AM EDT - 2 months ago

Dynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy

Dynavax to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025

Apr 22, 2025, 4:00 PM EDT - 3 months ago

Dynavax to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Apr 21, 2025, 4:05 PM EDT - 3 months ago

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Dynavax Files Definitive Proxy Statement and Sends Letter to Stockholders

Apr 17, 2025, 7:15 AM EDT - 3 months ago

Dynavax Files Definitive Proxy Statement and Sends Letter to Stockholders

Deep Track Capital Comments on Dynavax Technologies' Rejection of Most Recent Settlement Offer

Apr 16, 2025, 8:00 AM EDT - 3 months ago

Deep Track Capital Comments on Dynavax Technologies' Rejection of Most Recent Settlement Offer

Dynavax Files Preliminary Proxy Statement

Apr 3, 2025, 5:40 PM EDT - 3 months ago

Dynavax Files Preliminary Proxy Statement

Deep Track Capital Sends Letter to Dynavax Technologies' Board of Directors

Mar 10, 2025, 8:00 AM EDT - 4 months ago

Deep Track Capital Sends Letter to Dynavax Technologies' Board of Directors

Dynavax Announces Convertible Debt Refinancing and Common Stock Share Repurchase

Mar 6, 2025, 6:00 AM EST - 4 months ago

Dynavax Announces Convertible Debt Refinancing and Common Stock Share Repurchase

Dynavax Technologies: A Post-Earnings Assessment With Growing Market Share

Mar 3, 2025, 5:58 PM EST - 4 months ago

Dynavax Technologies: A Post-Earnings Assessment With Growing Market Share

Dynavax to Participate in Upcoming Investor Conferences

Feb 25, 2025, 4:10 PM EST - 5 months ago

Dynavax to Participate in Upcoming Investor Conferences

Dynavax Technologies Corporation (DVAX) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 6:38 PM EST - 5 months ago

Dynavax Technologies Corporation (DVAX) Q4 2024 Earnings Call Transcript

Dynavax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Financial Guidance

Feb 20, 2025, 4:01 PM EST - 5 months ago

Dynavax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Financial Guidance

Dynavax Responds to Deep Track and Highlights Long-Term Value Creation Strategy

Feb 19, 2025, 4:52 PM EST - 5 months ago

Dynavax Responds to Deep Track and Highlights Long-Term Value Creation Strategy

Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies' Board of Directors at 2025 Annual Meeting

Feb 19, 2025, 9:00 AM EST - 5 months ago

Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies' Board of Directors at 2025 Annual Meeting

Exclusive: Investor Deep Track launches proxy fight at Dynavax, nominates 4 directors

Feb 19, 2025, 8:04 AM EST - 5 months ago

Exclusive: Investor Deep Track launches proxy fight at Dynavax, nominates 4 directors

Goldman Sachs Turns Bearish On Vaccine Maker Dynavax Amid Shingles And Hepatitis B Uncertainty

Feb 11, 2025, 3:11 PM EST - 5 months ago

Goldman Sachs Turns Bearish On Vaccine Maker Dynavax Amid Shingles And Hepatitis B Uncertainty

Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025

Feb 6, 2025, 5:42 PM EST - 5 months ago

Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025

Dynavax Advances Board Refreshment Program

Jan 27, 2025, 6:00 AM EST - 6 months ago

Dynavax Advances Board Refreshment Program

Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Highlights

Jan 13, 2025, 9:00 AM EST - 6 months ago

Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Highlights

Dynavax to Present at the 7th Annual Evercore HealthCONx Conference

Nov 26, 2024, 4:05 PM EST - 8 months ago

Dynavax to Present at the 7th Annual Evercore HealthCONx Conference

Dynavax Technologies: What The Stock Buyback Means.  What It Doesn't

Nov 13, 2024, 6:36 PM EST - 8 months ago

Dynavax Technologies: What The Stock Buyback Means.  What It Doesn't

Dynavax Announces $100 Million Accelerated Share Repurchase Program

Nov 11, 2024, 8:00 AM EST - 8 months ago

Dynavax Announces $100 Million Accelerated Share Repurchase Program

Dynavax Technologies Corporation (DVAX) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 7:46 PM EST - 8 months ago

Dynavax Technologies Corporation (DVAX) Q3 2024 Earnings Call Transcript

Dynavax Reports Third Quarter 2024 Financial Results and Provides Business Updates

Nov 7, 2024, 4:02 PM EST - 9 months ago

Dynavax Reports Third Quarter 2024 Financial Results and Provides Business Updates

Dynavax Announces $200 Million Share Repurchase Program

Nov 7, 2024, 4:01 PM EST - 9 months ago

Dynavax Announces $200 Million Share Repurchase Program

Glancy Prongay & Murray LLP Announces Investigation of Dynavax Technologies Corporation (DVAX)

Nov 6, 2024, 1:10 PM EST - 9 months ago

Glancy Prongay & Murray LLP Announces Investigation of Dynavax Technologies Corporation (DVAX)

Dynavax Adopts Limited-Duration Stockholder Rights Plan

Oct 29, 2024, 8:30 AM EDT - 9 months ago

Dynavax Adopts Limited-Duration Stockholder Rights Plan

Dynavax to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024

Oct 24, 2024, 4:10 PM EDT - 9 months ago

Dynavax to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024

3 'Repeatable' Biotech Trades

Sep 25, 2024, 12:46 PM EDT - 10 months ago

3 'Repeatable' Biotech Trades

FOLD GSK NTLA XBI

Dynavax Technologies: A Two Trick Pony Operating With A Single Trick

Aug 23, 2024, 4:32 AM EDT - 11 months ago

Dynavax Technologies: A Two Trick Pony Operating With A Single Trick

Dynavax Technologies Corporation (DVAX) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 8:54 PM EDT - 1 year ago

Dynavax Technologies Corporation (DVAX) Q2 2024 Earnings Call Transcript

Dynavax Reports Second Quarter 2024 Financial Results and Provides Business Updates

Aug 6, 2024, 4:01 PM EDT - 1 year ago

Dynavax Reports Second Quarter 2024 Financial Results and Provides Business Updates

KWalzz
KWalzz Jul. 16 at 12:06 PM
$DVAX more than a year ago the lazy dynavax crookies received the CRL for their dialysis fail ... wow, only one update and no meeting with FDA since then ... hey, Myers and Spencer, stop slurping martinis, go to work, this 4dose regimen is approved in EU so why still nothing here? go to work you lazy morns and create shareholder value ...
1 · Reply
Barry64
Barry64 Jul. 15 at 3:04 PM
$DVAX Extremely low volume. Easily manipulated.
1 · Reply
KWalzz
KWalzz Jul. 14 at 7:47 PM
$DVAX the only way to get this moved up is good news regarding dialysis fail - but this would mean WORK, WORK, WORK for the lazy Spencer & Myers crookies. I see nothing else in the mid-term to move this, except maybe more activism by Deep Track, next ER is not so far away ...
0 · Reply
KWalzz
KWalzz Jul. 13 at 6:05 PM
$DVAX btw, for the ones who care about SI, for the 4th time pretty unchanged, bit of unusual, but I do not read too much into it.
1 · Reply
KWalzz
KWalzz Jul. 13 at 5:22 AM
$DVAX all these mice studies which often date back 2022 or more will eventually grow up to human studies in 2030 or so, or maybe not and never. useless paid pump scam ....
0 · Reply
KWalzz
KWalzz Jul. 13 at 5:17 AM
$DVAX like clockwork, another pump that sounds like coming from a bot, not very smart, but so sure 20s soooooooooon .....
0 · Reply
AccuRoger
AccuRoger Jul. 12 at 7:11 PM
$DVAX partner, Mount Sinai is moving forward with its Influenza vaccine that has previously used CpG 1018 in animal studies (see references 13 and 14). The details in this article are technical but are a precursor to human trials. There seems to be a growth plan for DVAX; however, management has not shared it with investors. https://www.sciencedirect.com/science/article/pii/S0264410X25007686
0 · Reply
KWalzz
KWalzz Jul. 10 at 7:11 PM
$DVAX yes, of course 20 soon ... so so sooooon ...
1 · Reply
Quantum_Capital_LLC
Quantum_Capital_LLC Jul. 10 at 7:08 PM
$DVAX will test the 15 wall (July'22, Sept'23, Feb'25) soon enough and I believe base on technical indicators it will break thru, testing 20 again for a +50% to +100% gain. Do your DD. Long term
2 · Reply
OhioTrader
OhioTrader Jul. 10 at 3:53 PM
$DVAX really. $10.99. you guys are a tease!
0 · Reply
chrlaff01
chrlaff01 Jul. 10 at 1:35 PM
$DVAX Don’t be afraid of $11, little Dvax. It won’t hurt you.
0 · Reply
KWalzz
KWalzz Jul. 9 at 7:35 PM
$DVAX LOL, VRDN up 7%, now in the 17s, worth more than our 1-vaccine only and nothing else company ... VRDN can be glad they got rid of Scott Myers.
0 · Reply
KWalzz
KWalzz Jul. 9 at 7:30 PM
$DVAX my RARE and BBIO investments shine more and more, LOL ! and Dynavax? well, here we go ...
0 · Reply
Jpjecj
Jpjecj Jul. 9 at 3:04 PM
$DVAX
0 · Reply
Buy_dvax100
Buy_dvax100 Jul. 8 at 2:57 PM
$DVAX LFG!!!!!
0 · Reply
Buy_dvax100
Buy_dvax100 Jul. 7 at 7:30 PM
$DVAX Awfully quiet in this camp.. Long n STRONG 💪 🚀 🚀 🚀
0 · Reply
Buy_dvax100
Buy_dvax100 Jul. 7 at 6:09 PM
$DVAX
0 · Reply
Buy_dvax100
Buy_dvax100 Jul. 1 at 6:34 PM
$DVAX
1 · Reply
Buy_dvax100
Buy_dvax100 Jul. 1 at 3:49 PM
$DVAX Russell 3000?
0 · Reply
Dvax2theMoon
Dvax2theMoon Jul. 1 at 2:04 PM
$DVAX seen a clip online and wonder if we are in trouble with the latest RFK JR comments on hep B… 🤔
2 · Reply
martycar97
martycar97 Jun. 27 at 6:47 PM
$DVAX Our BOD’s are killing it after they won the vote. Business as usual.
2 · Reply
KWalzz
KWalzz Jun. 26 at 8:05 PM
$DVAX 7 cents up, WOW, is another mice trial or a trial completing in late 2028 around the corner? isnt this cool how strong this ticker was today? LMAO (what else)
1 · Reply